Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Peptilogics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11014
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technology, a propriety platform that breaks the bacterial membranes. Peptilogics’ eCAP possess preclinical effectiveness against the priority Eskape pathogens, both gram positive and gram negative bacterial infections. The company’s eCAPs target and disrupt bacterial membranes, which cause rapid bacterial death by causing cellular chemical imbalance without inducing lysis. It improves options for healthcare practitioners and patients across a multitude of indications. Peptilogics is headquartered in Pittsburgh, Pennsylvania, the US.

Peptilogics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptilogics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Peptilogics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Peptilogics Raises USD5.5 Million in Series A financing 10
Peptilogics Raises USD0.7 Million in Venture Financing 11
Peptilogics Raises USD0.4 Million in Financing Round 12
Peptilogics Inc – Key Competitors 13
Peptilogics Inc – Key Employees 14
Peptilogics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Peptilogics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptilogics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptilogics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Peptilogics Raises USD5.5 Million in Series A financing 10
Peptilogics Raises USD0.7 Million in Venture Financing 11
Peptilogics Raises USD0.4 Million in Financing Round 12
Peptilogics Inc, Key Competitors 13
Peptilogics Inc, Key Employees 14
Peptilogics Inc, Other Locations 15

List of Figures
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptilogics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invuity Inc (IVTY):医療機器:M&Aディール及び事業提携情報
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • OmniComm Systems Inc (OMCM):医療機器:M&Aディール及び事業提携情報
    Summary OmniComm Systems Inc (OmniComm) is a provider of electronic data capture and eClinical software and services. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative sites to securely …
  • China Gas Holdings Ltd (384):企業の財務・戦略的SWOT分析
    China Gas Holdings Ltd (384) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Shoaibi Group-石油・ガス分野:企業M&A・提携分析
    Summary Shoaibi Group (Shoaibi) is a provider of manufacturing, services, product distribution and investment programs. The company offers active venture capital and private equity investments. It offers services such as marketing and technical services, finance and taxation, public relations, admin …
  • Neptune Orient Lines Limited:企業の戦略・SWOT・財務情報
    Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report Summary Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Commonwealth Scientific and Industrial Research Organisation:製薬・医療:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Hazama Ando Corporation:企業の戦略・SWOT・財務情報
    Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report Summary Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aflac Incorporated:企業の戦略・SWOT・財務情報
    Aflac Incorporated - Strategy, SWOT and Corporate Finance Report Summary Aflac Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Trinity Industries Inc (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus Interlong) is a provider of cytokine protein therapeutic drugs and preventive biological products. The company provides products such as recombinant human interferon a-2b for injection, recombinant human interleukin-2 for injection a …
  • Otto Bock HealthCare GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. AFC Energy power generation technology is used in the industrial markets and produces heat, water, and electricity. The company provides its electricity for industrial a …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • U.S. Bancorp:企業のM&A・事業提携・投資動向
    U.S. Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Church & Dwight Co Inc:戦略・SWOT・企業財務分析
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報
    Summary JSR Corp (JSR), formerly Japan Synthetic Rubber Co Ltd is a chemical manufacturing company. It produces a synthetic rubbers, emulsions and plastics. The company, along with its subsidiaries, provides general-purpose synthetic rubbers, special purpose synthetic rubbers, thermoplastic elastome …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • TTK Prestige Limited:企業の戦略・SWOT・財務分析
    TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report Summary TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PartnerRe Ltd.:企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆